Marcelino, João
Giménez-Arnau, Ana M.
Funding for this research was provided by:
Universitat Pompeu Fabra
Article History
Accepted: 1 March 2024
First Online: 8 April 2024
Declarations
:
: Ana M. Giménez-Arnau is or recently was a speaker and/or advisor for and/or has received research funding from Almirall, Amgen, AstraZeneca, Avene, Celldex, Escient Pharmaceutials, Genentech, GSK, Instituto Carlos III- FEDER, Leo Pharma, Menarini, Mitsubishi Tanabe Pharma, Novartis, Sanofi–Regeneron, Servier, Thermo Fisher Scientific, Uriach Pharma/Noucor.João Marcelino declares that he has no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.